Shalby Limited

SHALBY NSE Healthcare Hospital
₹144.78
-0.81%
Delayed · cached 15 min

Fair value analysis

SHALBY
Shalby Limited
HealthcareHospital
₹145.96
Close used for this calculation
₹117.80Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
21/100
Profitability4/25
Returns7/25
Balance Sheet6/25
Efficiency4/25
Growth0/25
Weak
Quality radar
21Prof.4/25Ret.7/25Eff.4/25B.Sht6/25Growth0/25

Consensus fair value

₹117.80
Above FV
▼ -19.3% against the close used
Model range ₹24.16 – ₹177.50
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹24.16Fair value₹117.80Bull₹177.50
FairClose
52-week traded range
52W low ₹126.8052W high ₹266.83

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Shalby Limited closed at ₹145.96, 23.9% above the consensus fair value of ₹117.80 drawn from 7 valuation models.

Financial DNA score 21/100 — Weak. P/E of 39.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹64.85
-55.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹87.62
-40.0%
√(22.5 × EPS × BVPS)
EPS=3.46, BVPS=98.62 · outside Graham range (P/E 39.8, P/B 1.5) — asset-light, treat as a rough floor
P/E Fair Value
₹177.50
+21.6%
EPS × 51.3x (sector P/E)
EPS=3.46, Sector P/E=51.3x
EV/EBITDA
₹145.12
-0.6%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=2.15B
Book Value (P/B)
₹24.16
-83.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=98.62, ROE=2.5%, g=3%, r=10%
Reverse DCF
₹145.96
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 17.2% | Historical: 0%
Margin of Safety
₹82.49
-43.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=109.99, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.